Yesterday, a total of 48 stock ETFs increased by over 100 million shares, the Southern CSI 1000ETF increased by 1.366 billion shares, and the Huaxia CSI A500ETF increased by 1.35 billion shares.Guojin Securities: In 25 years or the first year of commercial mass production of humanoid robots, Guojin Securities said that Huawei's overweight body intelligence has become a new direction, which is expected to bring deterministic AI technology to domestic robot manufacturers and help domestic OEMs accelerate their rise. In 25 years or the first year of commercial mass production of humanoid robots, the domestic and international industries have resonated, and the humanoid robot industry has ushered in a period of rapid development and has plate investment opportunities. It is suggested to focus on the screw, reducer, torque sensor and domestic robot.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.
Yiming food hit the daily limit and recorded 12 consecutive boards, and Yiming food hit the daily limit and recorded 12 consecutive boards, with a turnover of 517 million yuan.South Korean prosecutors seized and searched the South Korean Special Forces Command. (CCTV News)The turnover of Shanghai and Shenzhen stock markets exceeded 500 billion.
The weighted share price index of Taiwan Stock Exchange fell 1% to 22,893.62 points.The yield of Australian 10-year government bonds continued to rise, rising by 5 basis points to 4.19%.Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14